114 related articles for article (PubMed ID: 38828848)
1. PAK2 promotes proliferation, migration, and invasion of lung squamous cell carcinoma through LIMK1/cofilin signaling pathway.
Wang C; Wang J; Xu R; Huang X; Li Q; Zhang C; Yuan B
J Biomed Res; 2024 May; ():1-14. PubMed ID: 38828848
[TBL] [Abstract][Full Text] [Related]
2. CISD2 promotes lung squamous carcinoma cell migration and invasion via the TGF-β1-induced Smad2/3 signaling pathway.
Zhang J; Pan L; Zhang S; Yang Y; Liang J; Ma S; Wu Q
Clin Transl Oncol; 2023 Dec; 25(12):3527-3540. PubMed ID: 37249759
[TBL] [Abstract][Full Text] [Related]
3. Effects of PAK4/LIMK1/Cofilin-1 signaling pathway on proliferation, invasion, and migration of human osteosarcoma cells.
Li ZF; Yao YD; Zhao YY; Liu Y; Liu ZH; Hu P; Zhu ZR
J Clin Lab Anal; 2020 Sep; 34(9):e23362. PubMed ID: 32463132
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-138 inhibits migration and invasion of non-small cell lung cancer cells by targeting LIMK1.
Tan Y; Hu H; Tan W; Jin L; Liu J; Zhou H
Mol Med Rep; 2016 Nov; 14(5):4422-4428. PubMed ID: 27665963
[TBL] [Abstract][Full Text] [Related]
5. Pak1/LIMK1/Cofilin Pathway Contributes to Tumor Migration and Invasion in Human Non-Small Cell Lung Carcinomas and Cell Lines.
Jang I; Jeon BT; Jeong EA; Kim EJ; Kang D; Lee JS; Jeong BG; Kim JH; Choi BH; Lee JE; Kim JW; Choi JY; Roh GS
Korean J Physiol Pharmacol; 2012 Jun; 16(3):159-65. PubMed ID: 22802696
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIR9-3HG enhances LIMK1 mRNA and protein levels to contribute to the carcinogenesis of lung squamous cell carcinoma via sponging miR-138-5p and recruiting TAF15.
Xiong Y; Yang C; Yang X; Ding C; Wang Q; Zhu H
Pathol Res Pract; 2022 Sep; 237():153941. PubMed ID: 35933883
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
8. DADS downregulates the Rac1-ROCK1/PAK1-LIMK1-ADF/cofilin signaling pathway, inhibiting cell migration and invasion.
Zhou Y; Su J; Shi L; Liao Q; Su Q
Oncol Rep; 2013 Feb; 29(2):605-12. PubMed ID: 23233092
[TBL] [Abstract][Full Text] [Related]
9. TMED3 promotes the progression and development of lung squamous cell carcinoma by regulating EZR.
Xie A; Xu X; Kuang P; Zhang L; Yu F
Cell Death Dis; 2021 Aug; 12(9):804. PubMed ID: 34429402
[TBL] [Abstract][Full Text] [Related]
10. M2-like tumor-associated macrophages promote epithelial-mesenchymal transition through the transforming growth factor β/Smad/zinc finger e-box binding homeobox pathway with increased metastatic potential and tumor cell proliferation in lung squamous cell carcinoma.
Sumitomo R; Menju T; Shimazu Y; Toyazaki T; Chiba N; Miyamoto H; Hirayama Y; Nishikawa S; Tanaka S; Yutaka Y; Yamada Y; Nakajima D; Ohsumi A; Hamaji M; Sato A; Yoshizawa A; Huang CL; Haga H; Date H
Cancer Sci; 2023 Dec; 114(12):4521-4534. PubMed ID: 37806311
[TBL] [Abstract][Full Text] [Related]
11. P21 activated kinase 2 promotes pancreatic cancer growth and metastasis.
Yao GW; Bai JR; Zhang DP
Oncol Lett; 2019 Apr; 17(4):3709-3718. PubMed ID: 30930982
[TBL] [Abstract][Full Text] [Related]
12. GNA13 promotes the proliferation and migration of lung squamous cell carcinoma cells through regulating the PI3K/AKT signaling pathway.
Na J; Zhou W; Yin M; Hu Y; Ma X
Tissue Cell; 2022 Jun; 76():101795. PubMed ID: 35413491
[TBL] [Abstract][Full Text] [Related]
13. LINC01936 inhibits the proliferation and metastasis of lung squamous cell carcinoma probably by EMT signaling and immune infiltration.
Tian Q; Liu X; Li A; Wu H; Xie Y; Zhang H; Wu F; Chen Y; Bai C; Zhang X
PeerJ; 2023; 11():e16447. PubMed ID: 38084139
[TBL] [Abstract][Full Text] [Related]
14. FUBP1 promotes the proliferation of lung squamous carcinoma cells and regulates tumor immunity through PD-L1.
Yu J; Peng W; Xue Y; Li Y; Yang L; Geng Y
Allergol Immunopathol (Madr); 2022; 50(5):68-74. PubMed ID: 36086966
[TBL] [Abstract][Full Text] [Related]
15. TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment.
Guo Y; Hao Y; Shen L; Du Y; Wang X; Gao L; Feng X; Zhai Y; Liu Z; Xu E; Yang Y; Xi Y; Yang B; Zhang L
Cancer Cell Int; 2023 Nov; 23(1):285. PubMed ID: 37986192
[TBL] [Abstract][Full Text] [Related]
16. [Mechanism Research of lncRNA miR143HG on Regulating the Biological Behavior
of Lung Squamous Cell Carcinoma H520 Cells].
Gou L; He Y; Qiu P; Huang B
Zhongguo Fei Ai Za Zhi; 2023 Oct; 26(10):741-752. PubMed ID: 37989337
[TBL] [Abstract][Full Text] [Related]
17. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
[TBL] [Abstract][Full Text] [Related]
18. PTBP3 regulates proliferation of lung squamous cell carcinoma cells via CDC25A-mediated cell cycle progression.
Chen Y; Ji Y; Liu S; Liu Y; Feng W; Jin L
Cancer Cell Int; 2022 Jan; 22(1):19. PubMed ID: 35016691
[TBL] [Abstract][Full Text] [Related]
19. Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathway.
Liu P; Zhang R; Han L; Zhang X; Ye Y; Yu W; Ren X; Zhang W; Yu J
Ann Transl Med; 2022 Jan; 10(2):39. PubMed ID: 35282047
[TBL] [Abstract][Full Text] [Related]
20. miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting
Shan X; Zhang C; Li C; Fan X; Song G; Zhu J; Cao R; Zhang X; Zhu W
Cancer Pathog Ther; 2023 Apr; 1(2):87-97. PubMed ID: 38328402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
